Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.

Cardiac Surgery Research

Clinical Research

Research is an integral part of our mission in the Weill Cornell Department of Cardiothoracic Surgery. We strive to understand the pathophysiologic mechanisms of cardiovascular disease, develop and improve treatment methodologies, and improve the quality of the care that we offer. We have an active clinical and translational research center that focuses on the major cardiovascular disorders including coronary artery disease, heart valve disorders, and aortic pathologies, such as aneurysms and other aortopathies.

Clinical Trials

Our department participates in numerous national trials sponsored by industry representatives. We participate in studies to evaluate a variety of novel cardiac implants, such as innovative heart valve implants, heart valve repair techniques, aortic grafts, ventricular assist devices, and end-organ preservation devices. Learn more

  • Aortic Disease

  • Coronary Artery Disease

  • Atrial Fibrillation

  • Valvular Disease

Our Researchers

<a href="https://vivo.weill.cornell.edu/display/cwid-lngirard">Leonard N Girardi, M.D.</a>

Leonard N Girardi, M.D.

Chair of Cardiothoracic Surgery

<a href="https://vivo.weill.cornell.edu/display/cwid-mfg9004">Mario FL Gaudino, M.D.</a>

Mario FL Gaudino, M.D.

Assistant Dean of Clinical Research;
Director of the JCTO;
Director of Translations and Clinical Research

<a href="https://vivo.weill.cornell.edu/display/cwid-slmick">Stephanie L Mick, M.D.</a>

Stephanie L Mick, M.D.

Associate Professor of Cardiothoracic Surgery

<a href="https://vivo.weill.cornell.edu/display/cwid-chl9077">Christopher Lau, M.D.</a>

Christopher Lau, M.D.

Associate Professor of Cardiothoracic Surgery

Director of Research Administration

Murtaza Malbari, MS

Murtaza Malbari, MS

Director of Research Administration
Phone: (212) 746-9400
Fax: (212) 746-9393
mum2003@med.cornell.edu

PCORI Logo

A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery and assistant dean for clinical trials at Weill Cornell Medicine, has been approved for a nearly $30 million funding award from the Patient-Centered Outcomes Research Institute (PCORI). Learn More

The ROMA Trial

Dr. Gaudino is also one of the Principal Investigators of The ROMA Trial, a two-arm event-driven randomized multi-center trial aimed at evaluating the impact of the use of one ITA vs two or more AGs for CABG on a composite of death from any cause, any stroke, and post-discharge myocardial infarction and/or repeat revascularization.

JCTO

Dr. Mario Gaudino is the newly appointed director of the Joint Clinical Trials Office (JCTO) at Weill Cornell Medicine | NewYork-Presbyterian, Dr. Gaudino oversees ongoing clinical trials and lead strategic planning efforts.

Weill Cornell Medicine Cardiothoracic Surgery 525 East 68th Street
Box 110
Suite M 404
New York, NY 10065 Directions
Phone: (212) 746-5166

News

Cardiac Surgeons Issue ‘Call to Action’ to Improve CABG Outcomes in Women

One trial that may close the research gap is ROMA-WomenMario Gaudino, MD, PhD (Weill Cornell Medicine, New York, NY), one of the principal investigators, said that while there are observational ...

Read More

Valley Health System Participates in First Cardiac Surgery Clinical Trial for Women

Valley Health System is pleased to participate in the ROMA: WOMEN clinical trial, the first cardiovascular surgery clinical trial in women. Valley recently enrolled its first two patients in the trial. Sponsored by Weill Medical College of Cornell University and The Starr Foundation, the trial is designed to determine which bypass graft type is more effective for women with coronary artery disease...

Read More

Scientists Detail Major Mechanism Lung Cancers Use to Evade Immune Attack

A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack, according to a study led by researchers at Weill Cornell Medicine. The discovery could hasten the development of treatments that overcome this tumor defense mechanism and improve outcomes for lung cancer patients. Click...

Read More